|

High-dose trivalent inactivated influenza vaccine (HD-IIV3) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Asan Medical Center1

Indications

  • Immunogenicity1
  • Influenza1
  • Hematologic Neoplasms1
  • Cancer1

Other1 trial

Influenza Vaccination Strategy for Patients With Hematologic Malignancy
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.